Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycobacterium bovis (M. vaccae, "Wei Ka") for prevention of tuberculosis in high-risk individuals
CTR20130462Phase 3Completed
- Sponsor
- Anhui Zhifei Longcom Biopharmaceutical
- Start
- Jan 2015
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of mycobacterium vaccae in Tuberculosis (TB), sponsored by Anhui Zhifei Longcom Biopharmaceutical. Started Jan 2015; status: completed.
02
Drugs
mycobacterium vaccae
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on CTR20130462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130462.